Back to Somaí Pharmaceuticals or All Vape Cartridges

Dosing Look-Up Table (Estimated)

0.01/g80/mg THCTrace CBD
0.05/g400/mg THCTrace CBD
0.1/g800/mg THCTrace CBD
0.15/g1200/mg THCTrace CBD
0.2/g1600/mg THCTrace CBD
0.25/g2000/mg THCTrace CBD
0.3/g2400/mg THCTrace CBD
/gCalculate THCCalculate CBD

Please note values above are based on registered THC/CBD percentages, subject to ±10% allowed variance. Values provided are 'best case', losses to air during vaporisation or combustion will always occur.

Medication Details

Brand
Portugal Somaí Pharmaceuticals
Designation
Senses Red RS T800
Chemotype
Type I: High THC
THC Potential Range (±10%)
720-880mg
CBD Potential Range (±10%)
<1mg
Cultivated in
Flag of Portugal Portugal
Imported by
United Kingdom IPS Pharma
Imported as
Schedule II: Finished Product
Formulated in
Flag of Portugal Portugal

Stock Availability

We provide stock/pharmacy information only for use by medical cannabis patients, clinicians and pharmacists*.

Best-Known Status: Confirming Details

We try to ascertain stock status strictly based on the importer/distributor supplying pharmacies. Availability at individual pharmacies will differ.

*Cannabis is a controlled-substance and can only be legally dispensed upon submission of a valid prescription from a prescribing clinic, ordinarily listed.

Main Partner Pharmacy

Pharmacy Distributor

Dispensing Patient Pharmacies

Project Twenty21

Available on T21, a research project offering participating patients several discounted medications:

Participating Pharmacies:
Product Description Video Reviews0 Patient Reviews

About Senses Red RS T800

Further information to follow.

Portugal About Somai Pharmaceuticals Inc

Somaí Pharmaceuticals Logo

Somaí Pharmaceuticals is a manufacturer of cannabinoid formulations for the European markets.

At Somaí, we are committed to delivering the full therapeutic value of medical cannabis to benefit patients across the world.

Our scientific expertise combined with an avant-garde approach creates novel treatments that truly engage the power of the plant to alleviate debilitating chronic conditions.

We demonstrate our clear vision in the way we conceptualise innovative pharmaceutical products derived from cannabis and make them a reality.

Our team of experts formulate the most effective active ingredients to maximise bioavailability and provide rapid, targeted relief for specific conditions. Furthermore, our innovative drug delivery approaches ensure wide accessibility to our range.

Through collaboration with leading clinical experts and researchers across a variety of therapy areas, we aim to produce tailored, effective products and address currently unmet clinical needs through our forward-thinking approach.

somaipharma.eu

  Information provided is partially community sourced and may be outdated or otherwise incorrect. Please report any inaccuracies found by email.

NHS LogoFurther National Health-Service Information on Cannabis-Based Products for Medicinal Use (CBPMs)